Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019

Alzheimer Diagnostic Tests are blood test that detects the disease before it causes the symptoms. It measures key proteins or protein patterns in blood or spinal fluid (biomarkers). GlobalData's Medical Devices sector report, “Alzheimer Diagnostic Tests – Medical Devices Pipeline Assessment, 2019" provides comprehensive information about the Alzheimer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Alzheimer Diagnostic Tests Pipeline Assessment report provides key information and data related to:

Extensive coverage of the Alzheimer Diagnostic Tests under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Alzheimer Diagnostic Tests pipeline products.

Review of Recent Developments in the segment / industry

The Alzheimer Diagnostic Tests Pipeline Assessment report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2009 and forecast to 2023

• 4,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape

• 56,000+ medical equipment company profiles

• 4,300+ company profiles of medical equipment manufacturers in China and India

• 2,000+ company profiles of medical equipment manufacturers in Japan

• 825+ companies’ revenue splits and market shares

• 1,900+ quarterly and annual medical equipment company financials

• 940+ medical equipment company SWOTs

• 21,500+ pipeline product profiles

• 34,500+ marketed product profiles

• 36,000+ clinical trials

• 36,500+ trial investigators

• 5,400+ reports on companies with products in development

• 33,000+ deals in the medical equipment industry

• 1,300+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Alzheimer Diagnostic Tests under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Alzheimer Diagnostic Tests and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

– Identify and understand important and diverse types of Alzheimer Diagnostic Tests under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

AC Immune SA

Acobiom

Acumen Pharmaceuticals Inc

Adlyfe Inc

Admit Therapeutics SL

ADx NeuroSciences NV

Aelan Cell Technologies

Agent Biotech

Albert Ludwigs University of Freiburg

Alere Inc

Alzhyme Pty Ltd

Alzinova AB

Alzohis

Amarantus Bioscience Holdings Inc

Amarantus Diagnostics Inc

Amco International Manufacturing Inc.

Amoneta Diagnostics SAS

Amprion Inc

Applied NeuroSolutions, Inc. (Inactive)

Arkley Biotek LLC

attyloid GmbH

Banyan Biomarkers Inc

BioArctic AB

Bioasis Technologies Inc

Biomedical Development Corp

BioSystems International

Boston University Medical Campus

Brigham and Women's Hospital

C2N Diagnostics LLC

Cassava Sciences Inc

Chronix Biomedical Inc

Cleveland Diagnostics Inc.

Cofactor Genomics Inc

Cognext Diagnostics LLC

Columbia University

CompanDX Ltd

Cymedx

Cytox Ltd

Diadem SRL

DiaGenic ASA

DiamiR LLC

DiaPat GmbH

Durin Technologies, Inc.

Emory University

Eurobio Scientific SA

Florida Institute of Technology

French National Institute of Health and Medical Research

Fujirebio Diagnostics Inc

Fujirebio Europe NV

Ghent University

Grifols SA

IASO BioMed Inc

IBM Research-Australia

ICDD-sas

Inbiomed

Innosense LLC

Innovative Health Diagnostics

Instituto de Estructura de la Materia

Integrated Diagnostics Inc (Inactive)

Janssen Pharmaceutica NV

Johns Hopkins University

Johns Hopkins University School of Medicine

KineMed Inc

King's College London

Laboratory Corp of America Holdings

McGill University Health Center

Medifron DBT Inc

Memory Dx LLC

Meso Scale Diagnostics LLC

Michigan State University

Myriad RBM Inc

NanoSomiX, Inc.

Nanosphere Inc

National University of Singapore

NeoNeuro SAS

Neuro Bio Ltd

NeuroDiagnostics LLC

NeuroQuest Ltd

Neurotrope Bioscience Inc

Newcastle University

Novel Bio-spectrum Technologies Inc (Inactive)

Oligomerix inc

Orasi Medical, Inc. (Inactive)

Oryzon Genomics SA

Peri Rx Inc

Pre Diagnostics AS

Predemtec GmbH

ProMIS Neurosciences Inc

Proplex Technologies Llc

Protagen AG

Proteome Sciences Plc

Proteomics International Laboratories Ltd

Quanterix Corp

Redox Diagnostics LLC

Roche Diagnostics GmbH

Roche Diagnostics International Ltd

Rockefeller University

Ruhr-University Bochum

Scout Diagnostics LLC

Seer Biosciences Inc

Siemens Healthineers AG

SomaLogic Inc

StageZero Life Sciences Ltd

TauRx Pharmaceuticals Ltd

The Florey Institute of Neuroscience and Mental Health

The University of Nottingham

Todos Medical

Trinity College Dublin

True Diagnostics Inc

University of Calgary

University of Chicago

University of Georgia

University of Gottingen

University of Illinois at Chicago

University of Luxembourg

University of Maryland Baltimore

University of Oxford

University of Pittsburgh

University of South Florida

University of Texas Health Science Center at Houston

University of Texas Southwestern Medical Center

Urvogelbio Pvt Ltd

US Biomarkers Inc

vall d hebron institut de Recerca

Vitruvian Biomedical Inc

Washington University in St Louis

Washington University School of Medicine

Zoiray Technologies Inc.

Table of Contents

1 Table of Contents 2

1.1 List of Tables 12

1.2 List of Figures 20

2 Introduction 21

2.1 Alzheimer Diagnostic Tests Overview 21

3 Products under Development 22

3.1 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 22

3.2 Alzheimer Diagnostic Tests – Pipeline Products by Territory 23

3.3 Alzheimer Diagnostic Tests – Pipeline Products by Regulatory Path 24

3.4 Alzheimer Diagnostic Tests – Pipeline Products by Estimated Approval Date 25

3.5 Alzheimer Diagnostic Tests – Ongoing Clinical Trials 26

4 Alzheimer Diagnostic Tests – Pipeline Products under Development by Companies 27

4.1 Alzheimer Diagnostic Tests Companies – Pipeline Products by Stage of Development 27

4.2 Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 32

5 Alzheimer Diagnostic Tests Companies and Product Overview 37

5.1 AC Immune SA Company Overview 37

5.1.1 AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 37

5.2 Acobiom Company Overview 39

5.2.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 39

5.3 Acumen Pharmaceuticals Inc Company Overview 41

5.3.1 Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.4 Adlyfe Inc Company Overview 42

5.4.1 Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 42

5.5 Admit Therapeutics SL Company Overview 43

5.5.1 Admit Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 43

5.6 ADx NeuroSciences NV Company Overview 44

5.6.1 ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44

5.7 Aelan Cell Technologies Company Overview 51

5.7.1 Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 51

5.8 Agent Biotech Company Overview 52

5.8.1 Agent Biotech Pipeline Products & Ongoing Clinical Trials Overview 52

5.9 Albert Ludwigs University of Freiburg Company Overview 53

5.9.1 Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 53

5.10 Alere Inc Company Overview 54

5.10.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.11 Alzhyme Pty Ltd Company Overview 55

5.11.1 Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.12 Alzinova AB Company Overview 56

5.12.1 Alzinova AB Pipeline Products & Ongoing Clinical Trials Overview 56

5.13 Alzohis Company Overview 57

5.13.1 Alzohis Pipeline Products & Ongoing Clinical Trials Overview 57

5.14 Amarantus Bioscience Holdings Inc Company Overview 58

5.14.1 Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.15 Amarantus Diagnostics Inc Company Overview 59

5.15.1 Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 59

5.16 Amco International Manufacturing Inc. Company Overview 61

5.16.1 Amco International Manufacturing Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

5.17 Amoneta Diagnostics SAS Company Overview 62

5.17.1 Amoneta Diagnostics SAS Pipeline Products & Ongoing Clinical Trials Overview 62

5.18 Amprion Inc Company Overview 63

5.18.1 Amprion Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.19 Applied NeuroSolutions, Inc. (Inactive) Company Overview 64

5.19.1 Applied NeuroSolutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 64

5.20 Arkley Biotek LLC Company Overview 65

5.20.1 Arkley Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 65

5.21 attyloid GmbH Company Overview 66

5.21.1 attyloid GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

5.22 Banyan Biomarkers Inc Company Overview 67

5.22.1 Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.23 BioArctic AB Company Overview 68

5.23.1 BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 68

5.24 Bioasis Technologies Inc Company Overview 69

5.24.1 Bioasis Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.25 Biomedical Development Corp Company Overview 70

5.25.1 Biomedical Development Corp Pipeline Products & Ongoing Clinical Trials Overview 70

5.26 BioSystems International Company Overview 71

5.26.1 BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 71

5.27 Boston University Medical Campus Company Overview 72

5.27.1 Boston University Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 72

5.28 Brigham and Women's Hospital Company Overview 73

5.28.1 Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 73

5.29 C2N Diagnostics LLC Company Overview 74

5.29.1 C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 74

5.30 Cassava Sciences Inc Company Overview 77

5.30.1 Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.31 Chronix Biomedical Inc Company Overview 78

5.31.1 Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 78

5.32 Cleveland Diagnostics Inc. Company Overview 79

5.32.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 79

5.33 Cofactor Genomics Inc Company Overview 80

5.33.1 Cofactor Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.34 Cognext Diagnostics LLC Company Overview 81

5.34.1 Cognext Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81

5.35 Columbia University Company Overview 82

5.35.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 82

5.36 CompanDX Ltd Company Overview 84

5.36.1 CompanDX Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

5.37 Cymedx Company Overview 85

5.37.1 Cymedx Pipeline Products & Ongoing Clinical Trials Overview 85

5.38 Cytox Ltd Company Overview 86

5.38.1 Cytox Ltd Pipeline Products & Ongoing Clinical Trials Overview 86

5.39 Diadem SRL Company Overview 91

5.39.1 Diadem SRL Pipeline Products & Ongoing Clinical Trials Overview 91

5.40 DiaGenic ASA Company Overview 92

5.40.1 DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview 92

5.41 DiamiR LLC Company Overview 94

5.41.1 DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview 94

5.42 DiaPat GmbH Company Overview 95

5.42.1 DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 95

5.43 Durin Technologies, Inc. Company Overview 96

5.43.1 Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96

5.44 Emory University Company Overview 97

5.44.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 97

5.45 Eurobio Scientific SA Company Overview 98

5.45.1 Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 98

5.46 Florida Institute of Technology Company Overview 99

5.46.1 Florida Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 99

5.47 French National Institute of Health and Medical Research Company Overview 100

5.47.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 100

5.48 Fujirebio Diagnostics Inc Company Overview 101

5.48.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.49 Fujirebio Europe NV Company Overview 103

5.49.1 Fujirebio Europe NV Pipeline Products & Ongoing Clinical Trials Overview 103

5.50 Ghent University Company Overview 104

5.50.1 Ghent University Pipeline Products & Ongoing Clinical Trials Overview 104

5.51 Grifols SA Company Overview 105

5.51.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 105

5.52 IASO BioMed Inc Company Overview 106

5.52.1 IASO BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 106

5.53 IBM Research-Australia Company Overview 107

5.53.1 IBM Research-Australia Pipeline Products & Ongoing Clinical Trials Overview 107

5.54 ICDD-sas Company Overview 108

5.54.1 ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview 108

5.55 Inbiomed Company Overview 110

5.55.1 Inbiomed Pipeline Products & Ongoing Clinical Trials Overview 110

5.56 Innosense LLC Company Overview 111

5.56.1 Innosense LLC Pipeline Products & Ongoing Clinical Trials Overview 111

5.57 Innovative Health Diagnostics Company Overview 112

5.57.1 Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 112

5.58 Instituto de Estructura de la Materia Company Overview 113

5.58.1 Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview 113

5.59 Integrated Diagnostics Inc (Inactive) Company Overview 114

5.59.1 Integrated Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 114

5.60 Janssen Pharmaceutica NV Company Overview 115

5.60.1 Janssen Pharmaceutica NV Pipeline Products & Ongoing Clinical Trials Overview 115

5.61 Johns Hopkins University Company Overview 116

5.61.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 116

5.62 Johns Hopkins University School of Medicine Company Overview 117

5.62.1 Johns Hopkins University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 117

5.63 KineMed Inc Company Overview 118

5.63.1 KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 118

5.64 King's College London Company Overview 119

5.64.1 King's College London Pipeline Products & Ongoing Clinical Trials Overview 119

5.65 Laboratory Corp of America Holdings Company Overview 120

5.65.1 Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 120

5.66 McGill University Health Center Company Overview 123

5.66.1 McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 123

5.67 Medifron DBT Inc Company Overview 124

5.67.1 Medifron DBT Inc Pipeline Products & Ongoing Clinical Trials Overview 124

5.68 Memory Dx LLC Company Overview 125

5.68.1 Memory Dx LLC Pipeline Products & Ongoing Clinical Trials Overview 125

5.69 Meso Scale Diagnostics LLC Company Overview 126

5.69.1 Meso Scale Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 126

5.70 Michigan State University Company Overview 127

5.70.1 Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 127

5.71 Myriad RBM Inc Company Overview 128

5.71.1 Myriad RBM Inc Pipeline Products & Ongoing Clinical Trials Overview 128

5.72 NanoSomiX, Inc. Company Overview 129

5.72.1 NanoSomiX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129

5.73 Nanosphere Inc Company Overview 131

5.73.1 Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 131

5.74 National University of Singapore Company Overview 132

6.162 Jan 24, 2019: Medochemie & Pfizer partner in Vietnam 398

6.163 Jan 23, 2019: Proteome Sciences: Year end trading update 399

6.164 Jan 23, 2019: Up to 900 Pfizer staff to ballot for industrial action 400

6.165 Jan 22, 2019: Blood test detects Alzheimer's damage before symptoms 400

6.166 Jan 22, 2019: A blood test for Alzheimer's remains a distant possibility, study suggests 401

6.167 Jan 21, 2019: Early Prediction of Alzheimer’s Progression in Blood 402

6.168 Jan 16, 2019: Pain Therapeutics awarded $1.5 million research grant by National Institutes of Health 404

6.169 Jan 16, 2019: Mala Anand to join Agilent’s Board of Directors 404

6.170 Jan 16, 2019: James Borzi named Vice President, Global Supply Chain (CSCO) for GE Healthcare 405

6.171 Jan 16, 2019: Merck welcomes ten new startups to its Innovation Center 405

6.172 Jan 16, 2019: AllerGenis granted rights to develop and market its precision food allergy diagnostic using Luminex xMAP technology 406

6.173 Jan 15, 2019: Labcorp and Texas Association of Community Health Centers extend agreement for Labcorp to be exclusive laboratory for community health centers across texas 406

6.174 Jan 11, 2019: Amarantus Announces Commercialization Partnership With IDEA Pharma for Subsidiaries 407

6.175 Jan 11, 2019: Oxford BioDynamics: Board transition 408

6.176 Jan 09, 2019: Bioasis announces the appointment of Christine Antalik as Chief Financial Officer 408

6.177 Jan 08, 2019: Pfizer to exit two more plants in India 409

6.178 Jan 07, 2019: OPKO Health names Jon R. Cohen, M.D. executive chairman of BioReference Laboratories 410

6.179 Jan 07, 2019: Supreme Court hears oral arguments in drug labeling and foreclosure protections cases 410

6.180 Jan 07, 2019: Luminex announces preliminary revenue for the fourth quarter and full year 2018 411

6.181 Jan 03, 2019: AC Immune names Dr. Marie Kosco-Vilbois as Chief Scientific Officer 412

6.182 Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away 412

6.183 Dec 27, 2018: OPKO Health and OPKO's CEO and Chairman, Dr. Phillip Frost, announce proposed resolution of SEC action 413

6.184 Dec 27, 2018: Better mouse model built to enable precision-medicine research for Alzheimer's 414

6.185 Dec 20, 2018: NIH-developed test detects protein associated with Alzheimer’s and CTE 415

6.186 Dec 19, 2018: BioArctic employs Gunilla Andersson as Senior Director HR 415

6.187 Dec 18, 2018: X-Chem enters strategic collaboration with Bristol-Myers Squibb 416

6.188 Dec 17, 2018: Neurotrope announces the appointment of two new board members 417

6.189 Dec 17, 2018: ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board 417

6.190 Dec 11, 2018: Oxford BioDynamics: Final results for the year ended 30 september 2018 and notice of annual general meeting 419

6.191 Dec 10, 2018: Researchers to develop blood test for Alzheimer''s disease 424

6.192 Dec 10, 2018: Merck’s President of Global Human Health Adam H. Schechter to leave Merck Frank Clyburn named Chief Commercial Officer and Michael Nally named Chief Marketing Officer 424

6.193 Dec 10, 2018: Johns Hopkins team identifies promising diagnostic tool for Alzheimer's disease 425

6.194 Dec 10, 2018: Twist Bioscience statement 426

6.195 Dec 07, 2018: In Memoriam: Dr. Andreas Muhs CSO, scientific leader and friend has passed away 427

6.196 Dec 04, 2018: Cerebain initiates repositioning and review of business and corporate strategic growth plan 427

7 Appendix 428

7.1 Methodology 428

7.2 About GlobalData 431

7.3 Contact Us 431

7.4 Disclaimer 431

List of Tables

Table 1: Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 22

Table 2: Alzheimer Diagnostic Tests – Pipeline Products by Territory 23

Table 3: Alzheimer Diagnostic Tests – Pipeline Products by Regulatory Path 24

Table 4: Alzheimer Diagnostic Tests – Pipeline Products by Estimated Approval Date 25

Table 5: Alzheimer Diagnostic Tests – Ongoing Clinical Trials 26

Table 6: Alzheimer Diagnostic Tests Companies – Pipeline Products by Stage of Development 27

Table 7: Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 32

Table 8: AC Immune SA Pipeline Products & Ongoing Clinical Trials Overview 37

Table 13: Acobiom Pipeline Products & Ongoing Clinical Trials Overview 39

Table 18: Acumen Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Table 21: Adlyfe Inc Pipeline Products & Ongoing Clinical Trials Overview 42

Table 24: Admit Therapeutics SL Pipeline Products & Ongoing Clinical Trials Overview 43

Table 27: ADx NeuroSciences NV Pipeline Products & Ongoing Clinical Trials Overview 44

Table 46: Aelan Cell Technologies Pipeline Products & Ongoing Clinical Trials Overview 51

Table 49: Agent Biotech Pipeline Products & Ongoing Clinical Trials Overview 52

Table 52: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 53

Table 55: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Table 58: Alzhyme Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

Table 61: Alzinova AB Pipeline Products & Ongoing Clinical Trials Overview 56

Table 64: Alzohis Pipeline Products & Ongoing Clinical Trials Overview 57

Table 67: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Table 70: Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 59

Table 75: Amco International Manufacturing Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

Table 78: Amoneta Diagnostics SAS Pipeline Products & Ongoing Clinical Trials Overview 62

Table 81: Amprion Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Table 84: Applied NeuroSolutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 64

Table 87: Arkley Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview 65

Table 90: attyloid GmbH Pipeline Products & Ongoing Clinical Trials Overview 66

Table 93: Banyan Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 67

Table 96: BioArctic AB Pipeline Products & Ongoing Clinical Trials Overview 68

Table 99: Bioasis Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Table 102: Biomedical Development Corp Pipeline Products & Ongoing Clinical Trials Overview 70

Table 105: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview 71

Table 108: Boston University Medical Campus Pipeline Products & Ongoing Clinical Trials Overview 72

Table 111: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview 73

Table 114: C2N Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 74

Table 119: Cassava Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 77

Table 122: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 78

Table 125: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 79

Table 128: Cofactor Genomics Inc Pipeline Products & Ongoing Clinical Trials Overview 80

Table 131: Cognext Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 81

Table 134: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 82

Table 139: CompanDX Ltd Pipeline Products & Ongoing Clinical Trials Overview 84

Table 142: Cymedx Pipeline Products & Ongoing Clinical Trials Overview 85

Table 145: Cytox Ltd Pipeline Products & Ongoing Clinical Trials Overview 86

Table 155: Diadem SRL Pipeline Products & Ongoing Clinical Trials Overview 91

Table 158: DiaGenic ASA Pipeline Products & Ongoing Clinical Trials Overview 92

Table 163: DiamiR LLC Pipeline Products & Ongoing Clinical Trials Overview 94

Table 166: DiaPat GmbH Pipeline Products & Ongoing Clinical Trials Overview 95

Table 169: Durin Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96

Table 172: Emory University Pipeline Products & Ongoing Clinical Trials Overview 97

Table 175: Eurobio Scientific SA Pipeline Products & Ongoing Clinical Trials Overview 98

Table 178: Florida Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 99

Table 181: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 100

Table 184: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 101

Table 189: Fujirebio Europe NV Pipeline Products & Ongoing Clinical Trials Overview 103

Table 192: Ghent University Pipeline Products & Ongoing Clinical Trials Overview 104

Table 195: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 105

Table 198: IASO BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview 106

Table 201: IBM Research-Australia Pipeline Products & Ongoing Clinical Trials Overview 107

Table 204: ICDD-sas Pipeline Products & Ongoing Clinical Trials Overview 108

Table 209: Inbiomed Pipeline Products & Ongoing Clinical Trials Overview 110

Table 212: Innosense LLC Pipeline Products & Ongoing Clinical Trials Overview 111

Table 215: Innovative Health Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 112

Table 218: Instituto de Estructura de la Materia Pipeline Products & Ongoing Clinical Trials Overview 113

Table 221: Integrated Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 114

Table 224: Janssen Pharmaceutica NV Pipeline Products & Ongoing Clinical Trials Overview 115

Table 227: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 116

Table 230: Johns Hopkins University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 117

Table 233: KineMed Inc Pipeline Products & Ongoing Clinical Trials Overview 118

Table 236: King's College London Pipeline Products & Ongoing Clinical Trials Overview 119

Table 239: Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 120

Table 244: McGill University Health Center Pipeline Products & Ongoing Clinical Trials Overview 123

Table 247: Medifron DBT Inc Pipeline Products & Ongoing Clinical Trials Overview 124

Table 250: Memory Dx LLC Pipeline Products & Ongoing Clinical Trials Overview 125

Table 253: Meso Scale Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 126

Table 256: Michigan State University Pipeline Products & Ongoing Clinical Trials Overview 127

Table 259: Myriad RBM Inc Pipeline Products & Ongoing Clinical Trials Overview 128

Table 262: NanoSomiX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129

Table 267: Nanosphere Inc Pipeline Products & Ongoing Clinical Trials Overview 131

Table 270: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 132

Table 273: NeoNeuro SAS Pipeline Products & Ongoing Clinical Trials Overview 133

Table 276: Neuro Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 134

Table 279: NeuroDiagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 135

Table 282: NeuroQuest Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

Table 285: Neurotrope Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 137

Table 288: Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 138

Table 291: Novel Bio-spectrum Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139

Table 294: Oligomerix inc Pipeline Products & Ongoing Clinical Trials Overview 140

Table 297: Orasi Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 141

Table 300: Oryzon Genomics SA Pipeline Products & Ongoing Clinical Trials Overview 142

Table 305: Peri Rx Inc Pipeline Products & Ongoing Clinical Trials Overview 144

Table 308: Pre Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview 145

Table 311: Predemtec GmbH Pipeline Products & Ongoing Clinical Trials Overview 146

Table 314: ProMIS Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 147

Table 317: Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 148

Table 320: Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 149

Table 323: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 150

Table 330: Proteomics International Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview 153

Table 333: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview 154

Table 336: Redox Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 156

Table 339: Roche Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 157

Table 342: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 158

Table 347: Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview 160

Table 350: Ruhr-University Bochum Pipeline Products & Ongoing Clinical Trials Overview 161

Table 353: Scout Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 162

Table 356: Seer Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 163

Table 359: Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 164

Table 364: SomaLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 166

Table 367: StageZero Life Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 167

Table 370: TauRx Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 168

Table 373: The Florey Institute of Neuroscience and Mental Health Pipeline Products & Ongoing Clinical Trials Overview 169

Table 376: The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 170

Table 379: Todos Medical Pipeline Products & Ongoing Clinical Trials Overview 171

Table 384: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 174

Table 387: True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 175

Table 390: University of Calgary Pipeline Products & Ongoing Clinical Trials Overview 176

Table 393: University of Chicago Pipeline Products & Ongoing Clinical Trials Overview 177

Table 396: University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 178

Table 399: University of Gottingen Pipeline Products & Ongoing Clinical Trials Overview 179

Table 404: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 181

Table 409: University of Luxembourg Pipeline Products & Ongoing Clinical Trials Overview 183

Table 412: University of Maryland Baltimore Pipeline Products & Ongoing Clinical Trials Overview 184

Table 415: University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 185

Table 418: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 186

Table 421: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 187

Table 424: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 188

Table 427: University of Texas Southwestern Medical Center Pipeline Products & Ongoing Clinical Trials Overview 189

Table 430: Urvogelbio Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 190

Table 433: US Biomarkers Inc Pipeline Products & Ongoing Clinical Trials Overview 191

Table 436: vall d hebron institut de Recerca Pipeline Products & Ongoing Clinical Trials Overview 192

Table 439: Vitruvian Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 193

Table 442: Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 194

Table 447: Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 196

Table 452: Zoiray Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 199

Table 455: Glossary 430

List of Figures

Figure 1: Alzheimer Diagnostic Tests – Pipeline Products by Stage of Development 22

Figure 2: Alzheimer Diagnostic Tests – Pipeline Products by Territory 23

Figure 3: Alzheimer Diagnostic Tests – Pipeline Products by Regulatory Path 24

Figure 4: Alzheimer Diagnostic Tests – Pipeline Products by Estimated Approval Date 25

Figure 5: Alzheimer Diagnostic Tests – Ongoing Clinical Trials 26

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports